GlassScriptPhysician profile
Marizu Borrego
NPI 1003041666
$12,197.90
in general payments reported to CMS, 2019-2025
33 companies · $3,062 in 2025
The $3,062 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,910 · 2022: $1,887 · 2023: $2,661 · 2024: $2,678 · 2025: $3,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,311 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,311.26 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,670.91 | 2021-2025 | Enbrel, Otezla, Tavneos |
| Janssen Biotech, INC. | $1,673.66 | 2021-2025 | Tremfya, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $1,003.42 | 2022-2025 | |
| Ucb, INC. | $815.89 | 2021-2025 | Cimzia, Bimzelx |
| Lilly USA, LLC | $717.39 | 2021-2024 | Taltz |
| Mallinckrodt Hospital Products INC. | $622.25 | 2021-2025 | Acthar |
| Genentech USA, INC. | $596.60 | 2021-2025 | Actemra, Rituxan, Gazyva |
| Glaxosmithkline, LLC. | $593.17 | 2021-2025 | Benlysta, Nucala |
| Astrazeneca Pharmaceuticals LP | $460.46 | 2022-2025 | Saphnelo |
| Pfizer INC. | $444.36 | 2021-2025 | |
| Abbvie INC. | $355.18 | 2021-2025 | |
| Horizon Therapeutics Plc | $321.22 | 2021-2023 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $296.29 | 2023-2025 | Ofev, Cyltezo |
| Fresenius Kabi USA, LLC | $213.09 | 2023-2025 | Tyenne, Idacio |
| Pacira Therapeutics, INC. | $198.76 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $173.94 | 2022-2025 | Tymlos |
| E.R. Squibb & Sons, L.L.C. | $167.33 | 2022-2025 | Orencia |
| Pharmacosmos Therapeutics INC. | $148.82 | 2025 | Monoferric |
| Ani Pharmaceuticals, INC. | $138.12 | 2023-2025 | Purified Cortrophin Gel |
| Janssen Scientific Affairs, LLC | $99.51 | 2024 | Tremfya |
| Ferring Pharmaceuticals INC. | $98.50 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $74.47 | 2022 | |
| Celltrion USA INC. | $59.86 | 2025 | Vegzelma |
| Organon LLC | $54.94 | 2025 | Hadlima |
| Aurinia Pharma U.S., INC. | $37.54 | 2025 | Lupkynis |
| Boston Scientific Corporation | $31.27 | 2023 | Wavewriter Alpha Prime 16 |
| Hikma Pharmaceuticals USA | $28.95 | 2022-2023 | Mitigare |
| Genzyme Corporation | $21.14 | 2025 | |
| Octapharma USA, INC. | $20.00 | 2025 | Octagam Immune Globulin (Human) |
| Abbott Laboratories | $18.03 | 2024 | Proclaim |
| Sandoz INC. | $17.02 | 2023 | Hyrimoz |
| Cumberland Pharmaceuticals, INC. | $14.03 | 2021 | |
| Alexion Pharmaceuticals, INC. | $11.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marizu Borrego listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.